TrialInvestigational new drugs2024

Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects.

Hyun Chul Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.